Ask AI

Conference to Clinic: Advances in the Management of NPM1-Mutant and KMT2A-Rearranged AML

Improve your understanding of current and emerging menin inhibitors for the treatment of NPM1-mutant and KMT2A-rearranged AML to inform treatment strategies through downloadable slides.

Share

Program Content

Events

Activities

NPM1m and KMT2Ar AML
Conference to Clinic: Advances in the Management of NPM1-Mutant and KMT2A-Rearranged AML
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 02, 2025

Expires: July 01, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Kura Oncology, Inc.

Kura Oncology, Inc.